TIME: Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness
For the researchers at UCLA’s Jules Stein Eye Institute who launched the first-ever study to show that human embryonic stem cells may help reverse patients’ disease, the history-making day began at 4:30 a.m. It was an early morning wake-up call, to be sure, but a necessary one to prepare for the groundbreaking work that lay …
Continue reading “TIME: Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness”